Mark Perazella, MD

• Aldo Peixoto
• Dennis G Moledina
• F. Perry Wilson
• Gilbert Moeckel
• Harriet Kluger
• Jeffrey Testani
• Lloyd G. Cantley
• Ursula C Brewster

Dialysis; Hemodialysis Units, Hospital; HIV; Hypotension; Kidney Diseases; Kidney Failure, Chronic; Nephrology; Nephrogenic Fibrosing Dermopathy; Drug-Related Side Effects and Adverse Reactions

• Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.Moledina D, Obeid W, Smith R, Rosales I, Sise M, Moeckel G, Kashgarian M, Kuperman M, Campbell K, Lefferts S, Meliambro K, Bitzer M, Perazella M, Luciano R, Pober J, Cantley L, Colvin R, Wilson F, Parikh C. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. Journal Of Clinical Investigation 2023, 133 PMID: 37395276, PMCID: PMC10313360, DOI: 10.1172/jci168950.
• Contrast-Induced Acute Kidney Injury and Cardiovascular Imaging: Danger or Distraction?Davenport M, Perazella M, Nallamothu B. Contrast-Induced Acute Kidney Injury and Cardiovascular Imaging: Danger or Distraction? Circulation 2023, 147: 847-849. PMID: 36913495, DOI: 10.1161/circulationaha.122.062783.
• Acquired Disorders of HypomagnesemiaRosner M, Ha N, Palmer B, Perazella M. Acquired Disorders of Hypomagnesemia Mayo Clinic Proceedings 2023, 98: 581-596. PMID: 36872194, DOI: 10.1016/j.mayocp.2022.12.002.
• Safety and Adequacy of Kidney Biopsy Procedure in Patients with ObesityQian L, Menez S, Hu D, Weinstein J, Melchinger H, Thiessen Philbrook H, Luciano R, Turner J, Perazella M, Corona Villalobos C, Shaw M, Wilson F, Parikh C, Moledina D. Safety and Adequacy of Kidney Biopsy Procedure in Patients with Obesity Kidney360 2022, 10.34067/kid.0006602022. DOI: 10.34067/kid.0006602022.
• Safety and Adequacy of Kidney Biopsy Procedure in Patients with ObesityQian L, Menez S, Hu D, Weinstein J, Melchinger H, Thiessen-Philbrook H, Luciano R, Turner J, Perazella M, Villalobos C, Shaw M, Wilson F, Parikh C, Moledina D. Safety and Adequacy of Kidney Biopsy Procedure in Patients with Obesity Kidney360 2022, 4: 98-101. PMID: 36700910, DOI: 10.34067/kid.0006602022.
• Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosisKanbay M, Yildiz AB, Siriopol D, Vehbi S, Hasbal NB, Kesgin YE, Celayir M, Selcukbiricik F, Covic A, Perazella MA. Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis International Urology And Nephrology 2022, 55: 1025-1032. PMID: 36282399, DOI: 10.1007/s11255-022-03395-y.
• Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARY.Perazella MA. Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARY. Kidney360 2022, 3: 1491-1493. PMID: 36250736, PMCID: PMC9528384, DOI: 10.34067/KID.0008112021.
• Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injurySprangers B, Leaf DE, Porta C, Soler MJ, Perazella MA. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury Nature Reviews Nephrology 2022, 18: 794-805. PMID: 36168055, DOI: 10.1038/s41581-022-00630-8.
• The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysisKanbay M, Copur S, Siriopol D, Yildiz A, Berkkan M, Popa R, Hasbal N, Ortiz A, Perazella M. The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis Clinical Kidney Journal 2022 DOI: 10.1093/ckj/sfac194.
• The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysisKanbay M, Copur S, Siriopol D, Yildiz A, Berkkan M, Popa R, Hasbal N, Ortiz A, Perazella M. The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis Clinical Kidney Journal 2022, 16: 817-826. PMID: 37151409, PMCID: PMC10157786, DOI: 10.1093/ckj/sfac194.
• Drug-Induced Acute Kidney InjuryPerazella MA, Rosner MH. Drug-Induced Acute Kidney Injury Clinical Journal Of The American Society Of Nephrology 2022, 17: 1220-1233. PMID: 35273009, PMCID: PMC9435983, DOI: 10.2215/cjn.11290821.
• Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical TrialsSprangers B, Perazella MA, Lichtman SM, Rosner MH, Jhaveri KD. Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials Kidney International Reports 2022, 7: 1939-1950. PMID: 36090489, PMCID: PMC9458993, DOI: 10.1016/j.ekir.2022.06.005.
• Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsyTran AC, Melchinger H, Weinstein J, Shaw M, Kent C, Perazella MA, Wilson FP, Parikh CR, Moledina DG. Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy Practical Laboratory Medicine 2022, 30: e00271. PMID: 35465621, PMCID: PMC9018443, DOI: 10.1016/j.plabm.2022.e00271.
• Acute Interstitial Nephritis and Crystalline NephropathiesMoledina D, Herlitz L, Perazella M. Acute Interstitial Nephritis and Crystalline Nephropathies Nephrology Self-Assessment Program 2022, 21: 50-70. DOI: 10.1681/nsap.2022.21.1.5.
• Drug-Induced Osmotic Nephropathy: Add SGLT2-Inhibitors to the List?Perazella MA, Juncos LA. Drug-Induced Osmotic Nephropathy: Add SGLT2-Inhibitors to the List? Kidney360 2022, 3: 550-553. PMID: 35582186, PMCID: PMC9034826, DOI: 10.34067/kid.0007882021.
• Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapyBaker ML, Yamamoto Y, Perazella MA, Dizman N, Shirali AC, Hafez N, Weinstein J, Simonov M, Testani JM, Kluger HM, Cantley LG, Parikh CR, Wilson FP, Moledina DG. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy Journal For ImmunoTherapy Of Cancer 2022, 10: e004421. PMID: 35354588, PMCID: PMC8968986, DOI: 10.1136/jitc-2021-004421.
• Imaging Modalities for Acute Tubulointerstitial NephritisBaker M, Perazella M. Imaging Modalities for Acute Tubulointerstitial Nephritis 2022, 257-266. DOI: 10.1007/978-3-030-93438-5_20.
• Severe AKI in a Patient on Multiple Antimicrobial Agents for Leg InfectionRehan A, Moeckel GW, Perazella MA. Severe AKI in a Patient on Multiple Antimicrobial Agents for Leg Infection Kidney360 2022, 3: 405-406. PMID: 35373119, PMCID: PMC8967631, DOI: 10.34067/kid.0006102021.
• The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity.Moss EM, Perazella MA. The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity. Frontiers In Medicine 2022, 9: 964335. PMID: 36035427, PMCID: PMC9399765, DOI: 10.3389/fmed.2022.964335.
• Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data.Moledina DG, Eadon MT, Calderon F, Yamamoto Y, Shaw M, Perazella MA, Simonov M, Luciano R, Schwantes-An TH, Moeckel G, Kashgarian M, Kuperman M, Obeid W, Cantley LG, Parikh CR, Wilson FP. Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrology Dialysis Transplantation 2021, 37: 2214-2222. PMID: 34865148, PMCID: PMC9755995, DOI: 10.1093/ndt/gfab346.
• The Crystalline NephropathiesPerazella MA, Herlitz LC. The Crystalline Nephropathies Kidney International Reports 2021, 6: 2942-2957. PMID: 34901567, PMCID: PMC8640557, DOI: 10.1016/j.ekir.2021.09.003.
• Immunotherapy-Related Acute Kidney InjuryManohar S, Jhaveri KD, Perazella MA. Immunotherapy-Related Acute Kidney Injury Advances In Chronic Kidney Disease 2021, 28: 429-437.e1. PMID: 35190109, DOI: 10.1053/j.ackd.2021.07.006.
• The Challenges of Acute Interstitial Nephritis: Time to StandardizeMoledina DG, Perazella MA. The Challenges of Acute Interstitial Nephritis: Time to Standardize Kidney360 2021, 2: 1051-1055. PMID: 35373086, PMCID: PMC8791367, DOI: 10.34067/kid.0001742021.
• Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendationsPerazella MA, Sprangers B. Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations Clinical Kidney Journal 2021, 14: sfab052-. PMID: 33970161, PMCID: PMC8087122, DOI: 10.1093/ckj/sfab052.
• Genes, COVID-19, and phenotypeIzzedine H, Jhaveri KD, Perazella MA. Genes, COVID-19, and phenotype Clinical Kidney Journal 2021, 14: sfab044-. PMID: 34221375, PMCID: PMC7928999, DOI: 10.1093/ckj/sfab044.
• PARP inhibitors and the KidneyDeshpande P, Perazella M, Jhaveri K. PARP inhibitors and the Kidney Journal Of Onco-Nephrology 2021, 5: 42-47. DOI: 10.1177/2399369320987090.
• In Case of a Pandemic, Pivot: Moving the National Kidney Foundation Spring Clinical Meeting Online.Kramer H, Joseph J, Rosner MH, Perazella MA. In Case of a Pandemic, Pivot: Moving the National Kidney Foundation Spring Clinical Meeting Online. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 2021, 77: 1-3. PMID: 32976856, PMCID: PMC7511158, DOI: 10.1053/j.ajkd.2020.09.004.
• Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARY.Baker ML, Perazella MA. Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: COMMENTARY. Kidney360 2020, 1: 1192-1194. PMID: 35372870, PMCID: PMC8815502, DOI: 10.34067/kid.0004652020.
• Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney FoundationWeinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation Radiology 2020, 298: 202903. PMID: 33170103, DOI: 10.1148/radiol.2020202903.
• Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney FoundationWeinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation Kidney Medicine 2020, 3: 142-150. PMID: 33604544, PMCID: PMC7873723, DOI: 10.1016/j.xkme.2020.10.001.
• Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritisMoledina DG, Wilson FP, Kukova L, Obeid W, Luciano R, Kuperman M, Moeckel GW, Kashgarian M, Perazella MA, Cantley LG, Parikh CR. Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis Nephrology Dialysis Transplantation 2020, 36: 1851-1858. PMID: 33125471, PMCID: PMC8476079, DOI: 10.1093/ndt/gfaa169.
• Onconephrology: The intersections between the kidney and cancerRosner MH, Jhaveri KD, McMahon BA, Perazella MA. Onconephrology: The intersections between the kidney and cancer CA A Cancer Journal For Clinicians 2020, 71: 47-77. PMID: 32853404, DOI: 10.3322/caac.21636.
• Assessment of Interobserver Reliability of Nephrologist Examination of Urine Sediment.Palsson R, Colona MR, Hoenig MP, Lundquist AL, Novak JE, Perazella MA, Waikar SS. Assessment of Interobserver Reliability of Nephrologist Examination of Urine Sediment. JAMA Network Open 2020, 3: e2013959. PMID: 32821922, PMCID: PMC7442930, DOI: 10.1001/jamanetworkopen.2020.13959.
• Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?Izzedine H, Jhaveri KD, Perazella MA. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg? Clinical Nephrology 2020, 94: 11-13. PMID: 32452757, DOI: 10.5414/cn110217.
• Adverse Drug Effects in Patients with CKD: Primum Non Nocere.Perazella MA, Nolin TD. Adverse Drug Effects in Patients with CKD: Primum Non Nocere. Clinical Journal Of The American Society Of Nephrology 2020, 15: 1075-1077. PMID: 32611663, PMCID: PMC7409750, DOI: 10.2215/cjn.08890620.
• In Reply to ‘Contrast-Enhanced CT in Patients With Kidney Disease: Some Considerations in Response to the ACR/NKF Consensus’Perazella MA, Weinreb JC, Davenport MS. In Reply to ‘Contrast-Enhanced CT in Patients With Kidney Disease: Some Considerations in Response to the ACR/NKF Consensus’ Kidney Medicine 2020, 2: 501. PMID: 32775994, PMCID: PMC7406849, DOI: 10.1016/j.xkme.2020.06.002.
• NSAIDs in CKD: Are They Safe?Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? American Journal Of Kidney Diseases 2020, 76: 546-557. PMID: 32479922, DOI: 10.1053/j.ajkd.2020.03.023.
• How to determine kidney function in cancer patients?Sprangers B, Abudayyeh A, Latcha S, Perazella MA, Jhaveri KD. How to determine kidney function in cancer patients? European Journal Of Cancer 2020, 132: 141-149. PMID: 32361629, DOI: 10.1016/j.ejca.2020.03.026.
• Immune checkpoint inhibitors and immune-related adverse renal eventsHerrmann SM, Perazella MA. Immune checkpoint inhibitors and immune-related adverse renal events Kidney International Reports 2020, 5: 1139-1148. PMID: 32775813, PMCID: PMC7403510, DOI: 10.1016/j.ekir.2020.04.018.
• COVID-19 therapeutic options for patients with kidney diseaseIzzedine H, Jhaveri KD, Perazella MA. COVID-19 therapeutic options for patients with kidney disease Kidney International 2020, 97: 1297-1298. PMID: 32317113, PMCID: PMC7271263, DOI: 10.1016/j.kint.2020.03.015.
• Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.Perazella MA. Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary. Kidney360 2020, 1: 166-168. PMID: 35378019, PMCID: PMC8809261, DOI: 10.34067/KID.0001072019.
• Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceLevey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference Kidney International 2020, 97: 1117-1129. PMID: 32409237, DOI: 10.1016/j.kint.2020.02.010.
• Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI?Perazella MA. Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI? Brazilian Journal Of Nephrology 2020, 42: 1-3. PMID: 32129787, PMCID: PMC7213936, DOI: 10.1590/2175-8239-jbn-2019-0208.
• SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?Baker ML, Perazella MA. SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern? Journal Of Nephrology 2020, 33: 985-994. PMID: 32067179, DOI: 10.1007/s40620-020-00712-5.
• The kidney–cancer connection continues to growPerazella M. The kidney–cancer connection continues to grow Journal Of Onco-Nephrology 2020, 4: 26-27. DOI: 10.1177/2399369320916474.
• A Patient with Nephrotic Syndrome and Acute Flank Pain.Perazella MA. A Patient with Nephrotic Syndrome and Acute Flank Pain. Kidney360 2020, 1: 74-75. PMID: 35372858, PMCID: PMC8808488, DOI: 10.34067/kid.0000482019.
• Clinical Images in Nephrology and Dialysis: Welcome to an Educational Feature.Perazella MA, Juncos LA, Allon M. Clinical Images in Nephrology and Dialysis: Welcome to an Educational Feature. Kidney360 2020, 1: 5. PMID: 35372859, PMCID: PMC8808492, DOI: 10.34067/kid.0000472019.
• Introduction to Kidney 360.Allon M, Juncos LA, Perazella MA. Introduction to Kidney 360. Kidney360 2020, 1: 3-4. PMID: 35372862, PMCID: PMC8808487, DOI: 10.34067/kid.0000492019.
• Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease Consensus Statements from the American College of Radiology and the National Kidney FoundationDavenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, Rodby RA, Wang CL, Weinreb JC. Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease Consensus Statements from the American College of Radiology and the National Kidney Foundation Kidney Medicine 2020, 2: 85-93. PMID: 33015613, PMCID: PMC7525144, DOI: 10.1016/j.xkme.2020.01.001.
• Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney FoundationDavenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, Rodby RA, Wang CL, Weinreb JC. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation Radiology 2020, 294: 192094. PMID: 31961246, DOI: 10.1148/radiol.2019192094.
• Acute kidney injury in a patient with lymphomaPerazella M. Acute kidney injury in a patient with lymphoma Journal Of Onco-Nephrology 2020, 4: 66-67. DOI: 10.1177/2399369319899098.
• 18 Adverse kidney effects of immunotherapiesSALY D, PERAZELLA M. 18 Adverse kidney effects of immunotherapies 2020, 166-182.e3. DOI: 10.1016/b978-0-323-54945-5.00027-8.
• Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell TransplantationRenaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation Clinical Journal Of The American Society Of Nephrology 2019, 15: 289-297. PMID: 31836598, PMCID: PMC7015091, DOI: 10.2215/cjn.08580719.
• Improving Cancer Care for Patients With Chronic Kidney Disease.Sprangers B, Jhaveri KD, Perazella MA. Improving Cancer Care for Patients With Chronic Kidney Disease. Journal Of Clinical Oncology 2019, 38: 188-192. PMID: 31800342, DOI: 10.1200/jco.19.02138.
• Crying kidneys: Bilateral renal contrast leakGarcia-Carro C, Gabaldon A, Perazella M, Soler M. Crying kidneys: Bilateral renal contrast leak Journal Of Onco-Nephrology 2019, 3: 171-173. DOI: 10.1177/2399369319863064.
• Images in Onco-Nephrology: Welcome to a new feature in the Journal of Onco-NephrologyPerazella M, Cosmai L, Launay-Vacher V, Porta C. Images in Onco-Nephrology: Welcome to a new feature in the Journal of Onco-Nephrology Journal Of Onco-Nephrology 2019, 3: 168-168. DOI: 10.1177/2399369319861754.
• Diagnosing acute interstitial nephritis: considerations for cliniciansNussbaum E, Perazella M. Diagnosing acute interstitial nephritis: considerations for clinicians Clinical Kidney Journal 2019 DOI: 10.1093/ckj/sfz080.
• Atypical urinary crystals in a patient with acute kidney injuryPerazella M. Atypical urinary crystals in a patient with acute kidney injury Journal Of Onco-Nephrology 2019, 3: 169-170. DOI: 10.1177/2399369319860158.
• A Hospital-Based Program to Reduce Central Line-Associated Bloodstream Infections among Hospitalized Patients Receiving Hemodialysis Using a Central Venous Catheter for Vascular Access.Conwell P, Aniskiewicz M, Ghidini J, DeVaux L, Perazella M, Giullian J. A Hospital-Based Program to Reduce Central Line-Associated Bloodstream Infections among Hospitalized Patients Receiving Hemodialysis Using a Central Venous Catheter for Vascular Access. Nephrology Nursing Journal : Journal Of The American Nephrology Nurses' Association 2019, 46: 587-590. PMID: 31872988.
• Evolution of the kidney–cancer connectionPerazella M, Workeneh B, Chen S. Evolution of the kidney–cancer connection Journal Of Onco-Nephrology 2019, 3: 88-91. DOI: 10.1177/2399369319841616.
• Drug-Induced Acute Kidney InjuryLuciano R, Perazella M. Drug-Induced Acute Kidney Injury 2018, 145-163. DOI: 10.1007/978-1-4939-8628-6_9.
• The adverse kidney effects of cancer immunotherapiesSaly D, Perazella M. The adverse kidney effects of cancer immunotherapies Journal Of Onco-Nephrology 2018, 2: 56-68. DOI: 10.1177/2399369318808806.
• Cancer drugs and the glomerulusShah H, Uppal N, Perazella M. Cancer drugs and the glomerulus Journal Of Onco-Nephrology 2018, 2: 78-91. DOI: 10.1177/2399369318815418.
• Blue-green discoloration of urine and false nephrotic range proteinuria at dipstick urinalysisPoloni J, de Moraes Sassi M, de Oliveira T, Rotta L, Perazella M. Blue-green discoloration of urine and false nephrotic range proteinuria at dipstick urinalysis Clinica Chimica Acta 2018, 482: 74-77. PMID: 29608875, DOI: 10.1016/j.cca.2018.03.036.
• 35 Kidney Disease Caused by Therapeutic AgentsPerazella M, Shirali A. 35 Kidney Disease Caused by Therapeutic Agents 2018, 334-344. DOI: 10.1016/b978-0-323-47794-9.00035-4.
• Severe Orthostatic Hypotension Complicating Multiple MyelomaSury K, Mutter M, Moeckel G, Perazella M. Severe Orthostatic Hypotension Complicating Multiple Myeloma Journal Of Onco-Nephrology 2017, 1: e8-e12. DOI: 10.5301/jo-n.5000029.
• AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug ToxicityShah M, Perazella M. AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity Journal Of Onco-Nephrology 2017, 1: 188-197. DOI: 10.5301/jo-n.5000030.
• New Horizons in Nephrology: Update in Onco-NephrologyPerazella M. New Horizons in Nephrology: Update in Onco-Nephrology Journal Of Onco-Nephrology 2017, 1: 147-150. DOI: 10.5301/jo-n.5000033.
• Growth of the Kidney–Cancer ConnectionPerazella M. Growth of the Kidney–Cancer Connection Journal Of Onco-Nephrology 2017, 1: 71-73. DOI: 10.5301/jo-n.5000015.
• Update on the Renal Effects of Anticancer AgentsPerazella M. Update on the Renal Effects of Anticancer Agents Journal Of Onco-Nephrology 2017, 1: 170-178. DOI: 10.5301/jo-n.5000026.
• Acute Interstitial NephritisMoledina D, Perazella M. Acute Interstitial Nephritis 2017 DOI: 10.2310/nephro.12028.
• Crizotinib: Renal Safety EvaluationPerazella M, Izzedine H. Crizotinib: Renal Safety Evaluation Journal Of Onco-Nephrology 2017, 1: 49-56. DOI: 10.5301/jo-n.5000012.
• Renal Consults from the Oncology FloorPerazella M. Renal Consults from the Oncology Floor Journal Of Onco-Nephrology 2016, 1: 5-8. DOI: 10.5301/jo-n.5000002.
• Drug-Induced Hypertension in Chronic Kidney DiseaseVichot A, Perazella M. Drug-Induced Hypertension in Chronic Kidney Disease 2016, 261-298. DOI: 10.1007/978-1-4939-6436-9_12.
• Thrombotic Microangiopathy, Cancer, and Cancer DrugsIzzedine H, Perazella MA. Thrombotic Microangiopathy, Cancer, and Cancer Drugs American Journal Of Kidney Diseases 2015, 66: 857-868. PMID: 25943718, DOI: 10.1053/j.ajkd.2015.02.340.
• The Urine Sediment as a Biomarker of Kidney DiseasePerazella MA. The Urine Sediment as a Biomarker of Kidney Disease American Journal Of Kidney Diseases 2015, 66: 748-755. PMID: 25943719, DOI: 10.1053/j.ajkd.2015.02.342.
• CommentaryPerazella M. Commentary Clinical Chemistry 2015, 61: 701-702. DOI: 10.1373/clinchem.2014.231795.
• Drug-Induced Glomerular Disease: Direct Cellular InjuryMarkowitz GS, Bomback AS, Perazella MA. Drug-Induced Glomerular Disease: Direct Cellular Injury Clinical Journal Of The American Society Of Nephrology 2015, 10: 1291-1299. PMID: 25862776, PMCID: PMC4491280, DOI: 10.2215/cjn.00860115.
• Nierenerkrankung mit kristallinen Ablagerungen von Leichtketten: diagnostische Urinmikroskopie als „flüssige Nierenbiopsie“Luciano R, Castano E, Fogazzi G, Perazella M. Nierenerkrankung mit kristallinen Ablagerungen von Leichtketten: diagnostische Urinmikroskopie als „flüssige Nierenbiopsie“ Nieren- Und Hochdruckkrankheiten 2015, 44: 166-171. DOI: 10.5414/nhx01686.
• New drug toxicities in the onco-nephrology worldPerazella MA, Izzedine H. New drug toxicities in the onco-nephrology world Kidney International 2015, 87: 909-917. PMID: 25671763, DOI: 10.1038/ki.2015.30.
• Abstract 19099: The Fractional Excretion of Urea is Substantially Altered by Diuretics in Heart Failure Patients: Implications for its Use in the Evaluation of Worsening Renal FunctionCheng S, Laur O, Kula A, Onyebeke C, Coca S, Perazella M, Testani J. Abstract 19099: The Fractional Excretion of Urea is Substantially Altered by Diuretics in Heart Failure Patients: Implications for its Use in the Evaluation of Worsening Renal Function Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.19099.
• Crystalline-induced kidney disease: a case for urine microscopyLuciano RL, Perazella MA. Crystalline-induced kidney disease: a case for urine microscopy Clinical Kidney Journal 2014, 8: 131-136. PMID: 25815167, PMCID: PMC4370296, DOI: 10.1093/ckj/sfu105.
• 37 Kidney Disease Caused by Therapeutic AgentsPerazella M, Shirali A. 37 Kidney Disease Caused by Therapeutic Agents 2014, 326-336. DOI: 10.1016/b978-1-4557-4617-0.00037-6.
• The Author RepliesPerazella M. The Author Replies Kidney International 2012, 82: 936-937. DOI: 10.1038/ki.2012.287.
• Experience with outpatient computed tomographic-guided renal biopsy.Margaryan A, Perazella MA, Mahnensmith RL, Abu-Alfa AK. Experience with outpatient computed tomographic-guided renal biopsy. Clinical Nephrology 2010, 74: 440-5. PMID: 21084047, DOI: 10.5414/cnp74440.
• The Urinary Sediment: An Integrated View, 3rd editionPerazella M. The Urinary Sediment: An Integrated View, 3rd edition Kidney International 2010, 78: 1202-1203. DOI: 10.1038/ki.2010.402.
• Acute phosphate nephropathyMarkowitz GS, Perazella MA. Acute phosphate nephropathy Kidney International 2009, 76: 1027-1034. PMID: 19675530, DOI: 10.1038/ki.2009.308.
• Renal Vulnerability to Drug ToxicityPerazella MA. Renal Vulnerability to Drug Toxicity Clinical Journal Of The American Society Of Nephrology 2009, 4: 1275-1283. PMID: 19520747, DOI: 10.2215/cjn.02050309.
• CHAPTER 184 The Role of Extracorporeal Blood Purification Therapies in the Prevention of Radiocontrast Agent—Induced NephropathyCruz D, Perazella M, Ronco C. CHAPTER 184 The Role of Extracorporeal Blood Purification Therapies in the Prevention of Radiocontrast Agent—Induced Nephropathy 2009, 1000-1006. DOI: 10.1016/b978-1-4160-4252-5.50193-3.
• Proton pump inhibitors: acute interstitial nephritis and other renal effectsBrewster U, Perazella M. Proton pump inhibitors: acute interstitial nephritis and other renal effects 2008, 567-577. DOI: 10.1007/978-0-387-84843-3_25.
• The ReplyPerazella M, Rodby R. The Reply The American Journal Of Medicine 2008, 121: e13. DOI: 10.1016/j.amjmed.2007.08.031.
• Fellows Forum in Dialysis edited by Mark A. Perazella: Chemical Ablation of Parathyroid Hyperplasia for Recurrent Secondary Hyperparathyroidism in an AutograftCruz D, Perazella M. Fellows Forum in Dialysis edited by Mark A. Perazella: Chemical Ablation of Parathyroid Hyperplasia for Recurrent Secondary Hyperparathyroidism in an Autograft Seminars In Dialysis 2007, 11: 249-252. DOI: 10.1111/j.1525-139x.1998.tb00356.x.
• The ReplyKapoor J, Perazella M. The Reply The American Journal Of Medicine 2007, 120: e21. DOI: 10.1016/j.amjmed.2007.03.019.
• MidodrinePerazella M. Midodrine Seminars In Dialysis 2007, 10: 245-247. DOI: 10.1111/j.1525-139x.1997.tb00503.x.
• 174 Vasopressin Response in Intradialytic HypotensionRho M, Perazella M, Peixoto A, Parikh C, Brewster U. 174 Vasopressin Response in Intradialytic Hypotension American Journal Of Kidney Diseases 2007, 49: b68. DOI: 10.1053/j.ajkd.2007.02.181.
• Fellows’ Forum in Dialysis. Depression: A Common but Underrecognized Condition Associated with End‐Stage Renal DiseasePerazella M, Wang P, Watnick S. Fellows’ Forum in Dialysis. Depression: A Common but Underrecognized Condition Associated with End‐Stage Renal Disease Seminars In Dialysis 2004, 17: 237-241. PMID: 15144552, DOI: 10.1111/j.0894-0959.2004.17313.x.
• Intravenous Iron and the Risk of Infection in End‐Stage Renal Disease PatientsPerazella M, Brewster U, Perazella M. Intravenous Iron and the Risk of Infection in End‐Stage Renal Disease Patients Seminars In Dialysis 2004, 17: 57-60. PMID: 14717813, DOI: 10.1111/j.1525-139x.2004.17115.x.
• Use of Low Molecular Weight Heparins and Glycoprotein IIb/IIIa Inhibitors in Patients with Chronic Kidney DiseasePerazella M, Mosenkis A, Berns J. Use of Low Molecular Weight Heparins and Glycoprotein IIb/IIIa Inhibitors in Patients with Chronic Kidney Disease Seminars In Dialysis 2004, 17: 411-416. PMID: 15461751, DOI: 10.1111/j.0894-0959.2004.17351.x.
• Nephrogenic Fibrosing Dermopathy: An Unusual Skin Condition Associated with Kidney DiseasePerazella MA, Ishibe S, Perazella MA, Reilly RF. Nephrogenic Fibrosing Dermopathy: An Unusual Skin Condition Associated with Kidney Disease Seminars In Dialysis 2003, 16: 276-280. PMID: 12753692, DOI: 10.1046/j.1525-139x.2003.16053.x.
• Pharmacologic options available to treat symptomatic intradialytic hypotensionPerazella M. Pharmacologic options available to treat symptomatic intradialytic hypotension American Journal Of Kidney Diseases 2001, 38: s26-s36. PMID: 11602458, DOI: 10.1053/ajkd.2001.28092.
• Indinavir nephropathy revisited: A pattern of insidious renal failure with identifiable risk factorsReilly R, Tray K, Perazella M. Indinavir nephropathy revisited: A pattern of insidious renal failure with identifiable risk factors American Journal Of Kidney Diseases 2001, 38: e23.1-e23.6. PMID: 11576910, DOI: 10.1053/ajkd.2001.27732.
• Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugsPerazella M, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs The American Journal Of Medicine 2001, 111: 64-67. PMID: 11448662, DOI: 10.1016/s0002-9343(01)00757-4.
• COX-2 Inhibitors and the KidneyPerazella M. COX-2 Inhibitors and the Kidney Hospital Practice 2001, 36: 43-56. PMID: 11263799, DOI: 10.3810/hp.2001.03.230.
• NSAIDs and the Kidney Revisited: Are Selective Cyclooxygenase-2 Inhibitors Safe?Eras J, Perazella M. NSAIDs and the Kidney Revisited: Are Selective Cyclooxygenase-2 Inhibitors Safe? The American Journal Of The Medical Sciences 2001, 321: 181-190. PMID: 11269794, DOI: 10.1097/00000441-200103000-00005.
• Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool DialysateAlappan R, Cruz D, Abu-Alfa A, Mahnensmith R, Perazella M. Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool Dialysate American Journal Of Kidney Diseases 2001, 37: 294-299. PMID: 11157369, DOI: 10.1053/ajkd.2001.21292.
• Drug-induced hyperkalemia: old culprits and new offendersPerazella M. Drug-induced hyperkalemia: old culprits and new offenders The American Journal Of Medicine 2000, 109: 307-314. PMID: 10996582, DOI: 10.1016/s0002-9343(00)00496-4.
• Acute Renal Failure in HIV-Infected Patients: A Brief Review of Common CausesPerazella M. Acute Renal Failure in HIV-Infected Patients: A Brief Review of Common Causes The American Journal Of The Medical Sciences 2000, 319: 385-391. PMID: 10875295, DOI: 10.1016/s0002-9629(15)40779-7.
• Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patientsAbu-Alfa A, Cruz D, Perazella M, Mahnensmith R, Simon D, Bia M. Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients American Journal Of Kidney Diseases 2000, 35: 1076-1082. PMID: 10845820, DOI: 10.1016/s0272-6386(00)70043-6.
• Are selective COX-2 inhibitors nephrotoxic?Perazella M, Eras J. Are selective COX-2 inhibitors nephrotoxic? American Journal Of Kidney Diseases 2000, 35: 937-940. PMID: 10793030, DOI: 10.1016/s0272-6386(00)70266-6.
• Trimethoprim-Induced HyperkalaemiaPerazella M. Trimethoprim-Induced Hyperkalaemia Drug Safety 2000, 22: 227-236. PMID: 10738846, DOI: 10.2165/00002018-200022030-00006.
• Trimethoprim-Sulfamethoxazole Therapy in Outpatients: Is Hyperkalemia a Significant Problem?Alappan R, Buller G, Perazella M. Trimethoprim-Sulfamethoxazole Therapy in Outpatients: Is Hyperkalemia a Significant Problem? American Journal Of Nephrology 1999, 19: 389-394. PMID: 10393376, DOI: 10.1159/000013483.
• Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotensionCruz D, Mahnensmith R, Brickel H, Perazella M. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension American Journal Of Kidney Diseases 1999, 33: 920-926. PMID: 10213650, DOI: 10.1016/s0272-6386(99)70427-0.
• Review Articles: Approach to Patients with Intradialytic Hypotension: A Focus on Therapeutic OptionsPerazella M. Review Articles: Approach to Patients with Intradialytic Hypotension: A Focus on Therapeutic Options Seminars In Dialysis 1999, 12: 175-181. DOI: 10.1046/j.1525-139x.1999.99013.x.
• Crystal-induced acute renal failurePerazella M. Crystal-induced acute renal failure The American Journal Of Medicine 1999, 106: 459-465. PMID: 10225250, DOI: 10.1016/s0002-9343(99)00041-8.
• Extreme Hyperphosphatemia and Acute Renal Failure after a Phosphorus-Containing Bowel RegimenOrias M, Mahnensmith R, Perazella M. Extreme Hyperphosphatemia and Acute Renal Failure after a Phosphorus-Containing Bowel Regimen American Journal Of Nephrology 1999, 19: 60-63. PMID: 10085452, DOI: 10.1159/000013427.
• Ringer's lactate: An inexpensive and effective dialysate for continuous renal replacement therapyPerazella M, Cruz D. Ringer's lactate: An inexpensive and effective dialysate for continuous renal replacement therapy American Journal Of Kidney Diseases 1999, 33: 614-615. PMID: 10070931, DOI: 10.1016/s0272-6386(99)70206-4.
• Malignant HypertensionPerazella M, Mahnensmith R. Malignant Hypertension New England Journal Of Medicine 1998, 339: 1985. PMID: 9869670, DOI: 10.1056/nejm199812313392705.
• Acute Renal Failure and Intravenous Immune GlobulinPerazella M, Cayco A. Acute Renal Failure and Intravenous Immune Globulin American Journal Of Therapeutics 1998, 5: 399-404. PMID: 10099084, DOI: 10.1097/00045391-199811000-00008.
• Leg Pain and Swelling in an HIV-Infected Drug AbuserFormica R, Perazella M. Leg Pain and Swelling in an HIV-Infected Drug Abuser Hospital Practice 1998, 33: 195-197. PMID: 9793550, DOI: 10.1080/21548331.1998.11443771.
• Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.Perazella M, Kashgarian M, Cooney E. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria. Clinical Nephrology 1998, 50: 194-6. PMID: 9776425.
• Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocolCayco A, Abu-Alfa A, Mahnensmith R, Perazella M. Reduction in arteriovenous graft impairment: Results of a vascular access surveillance protocol American Journal Of Kidney Diseases 1998, 32: 302-308. PMID: 9708617, DOI: 10.1053/ajkd.1998.v32.pm9708617.
• Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up.Cruz D, Mahnensmith R, Brickel H, Perazella M. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Clinical Nephrology 1998, 50: 101-7. PMID: 9725781.
• A Boy with Headache, Fatigue, and WeaknessPerazella M. A Boy with Headache, Fatigue, and Weakness Hospital Practice 1998, 33: 193-196. PMID: 9562842, DOI: 10.1080/21548331.1998.11443680.
• Drug-Induced Acute Tubulointerstitial Nephritis: The Clinical SpectrumCruz D, Perazella M. Drug-Induced Acute Tubulointerstitial Nephritis: The Clinical Spectrum Hospital Practice 1998, 33: 151-164. PMID: 9484301, DOI: 10.1080/21548331.1998.11443642.
• Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients?Cruz D, Mahnensmith R, Perazella M. Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients? American Journal Of Kidney Diseases 1997, 30: 772-779. PMID: 9398120, DOI: 10.1016/s0272-6386(97)90081-0.
• In replyCruz D, Perazella M. In reply American Journal Of Kidney Diseases 1997, 30: 730-731. DOI: 10.1016/s0272-6386(97)90505-9.
• Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.Cayco A, Perazella M, Hayslett J. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. Journal Of The American Society Of Nephrology 1997, 8: 1788-94. PMID: 9355083, DOI: 10.1681/asn.v8111788.
• Hyperkalemia in the ElderlyPerazella M, Mahnensmith R. Hyperkalemia in the Elderly Journal Of General Internal Medicine 1997, 12: 646-656. PMID: 9346463, PMCID: PMC1497179, DOI: 10.1046/j.1525-1497.1997.07128.x.
• Acute renal failure and ketorolac.Buller G, Perazella M. Acute renal failure and ketorolac. Annals Of Internal Medicine 1997, 127: 493-4. PMID: 9313014, DOI: 10.7326/0003-4819-127-6-199709150-00022.
• Authors' replyPerazella M, Buller G. Authors' reply American Journal Of Kidney Diseases 1997, 29: 962-965. DOI: 10.1016/s0272-6386(97)90474-1.
• Biochemical aberrations in a dialysis patient following parathyroidectomyCruz D, Perazella M. Biochemical aberrations in a dialysis patient following parathyroidectomy American Journal Of Kidney Diseases 1997, 29: 759-768. PMID: 9159312, DOI: 10.1016/s0272-6386(97)90131-1.
• Hypertension and hypokalemia: unusual syndromes.Cruz D, Perazella M. Hypertension and hypokalemia: unusual syndromes. Connecticut Medicine 1997, 61: 67-75. PMID: 9066195.
• Dysuria in an Elderly Man with CardiomyopathyPerazella M, Mahnensmith R. Dysuria in an Elderly Man with Cardiomyopathy Hospital Practice 1997, 32: 147-154. PMID: 9006590, DOI: 10.1080/21548331.1997.11443412.
• Bone marrow transplant nephropathy: a case report and review of the literature.Cruz D, Perazella M, Mahnensmith R. Bone marrow transplant nephropathy: a case report and review of the literature. Journal Of The American Society Of Nephrology 1997, 8: 166-73. PMID: 9013462, DOI: 10.1681/asn.v81166.
• Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?Cruz D, Perazella M, Abu-Alfa A, Mahnensmith R. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? American Journal Of Kidney Diseases 1996, 28: 535-540. PMID: 8840943, DOI: 10.1016/s0272-6386(96)90464-3.
• A Middle-Aged Woman with Back and Flank PainCruz D, Perazella M, Mahnensmith R. A Middle-Aged Woman with Back and Flank Pain Hospital Practice 1996, 31: 193-209. PMID: 8814129, DOI: 10.1080/21548331.1996.11443354.
• Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.Perazella M, Mahnensmith R. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clinical Nephrology 1996, 46: 187-92. PMID: 8879854.
• Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.Alappan R, Perazella M, Buller G. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Annals Of Internal Medicine 1996, 124: 316-20. PMID: 8554227, DOI: 10.7326/0003-4819-124-3-199602010-00006.
• Mechanical mitral valve prosthesis dysfunction from thrombus: transesophageal echocardiography has limitations.Perazella M, Frederick W, Buller G, Widman S. Mechanical mitral valve prosthesis dysfunction from thrombus: transesophageal echocardiography has limitations. Connecticut Medicine 1996, 60: 75-7. PMID: 8820631.
• Acute renal failure after cardiac transplantation: a case report and review of the literature.Cruz D, Perazella M. Acute renal failure after cardiac transplantation: a case report and review of the literature. The Yale Journal Of Biology And Medicine 1996, 69: 461-8. PMID: 9381741, PMCID: PMC2589003.
• Hypercalcemia, sarcoidosis, and normal chest radiographsSander S, Buller G, Perazella M. Hypercalcemia, sarcoidosis, and normal chest radiographs The American Journal Of Medicine 1995, 99: 437-438. PMID: 7573103, DOI: 10.1016/s0002-9343(99)80196-x.
• Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levelsPerazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia M. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels American Journal Of Kidney Diseases 1995, 26: 495-500. PMID: 7645558, DOI: 10.1016/0272-6386(95)90496-4.
• ReplyBuller G, Perazella M. Reply American Journal Of Kidney Diseases 1995, 25: 661-662. DOI: 10.1016/0272-6386(95)90143-4.
• Single Voided Urine Protein/Creatinine RatioPerazella M. Single Voided Urine Protein/Creatinine Ratio Mayo Clinic Proceedings 1995, 70: 308-309. PMID: 7861823, DOI: 10.4065/70.3.308-b.
• Acute Nonspecific Illness in an AIDS Patient with DysphagiaPerazella M, Sadigh M. Acute Nonspecific Illness in an AIDS Patient with Dysphagia Hospital Practice 1994, 29: 39-47. PMID: 7962235, DOI: 10.1080/21548331.1994.11443104.
• Electrolyte and acid-base disorders associated with AIDSPerazella M, Brown E. Electrolyte and acid-base disorders associated with AIDS Journal Of General Internal Medicine 1994, 9: 232-236. PMID: 8014731, DOI: 10.1007/bf02600132.
• Nephrotic Syndrome Associated with Agnogenic Myeloid MetaplasiaPerazella M, Buller G. Nephrotic Syndrome Associated with Agnogenic Myeloid Metaplasia American Journal Of Nephrology 1994, 14: 223-225. PMID: 7977486, DOI: 10.1159/000168720.
• NSAID Nephrotoxicity Revisited: Acute Renal Failure Due to Parenteral KetorolacPERAZELLA M, BULLER G. NSAID Nephrotoxicity Revisited: Acute Renal Failure Due to Parenteral Ketorolac Southern Medical Journal 1993, 86: 1421-1424. PMID: 8272928, DOI: 10.1097/00007611-199312000-00025.
• Renal Failure and Severe Hypokalemia Associated With Acute Myelomonocytic LeukemiaPerazella M, Eisen R, Frederick W, Brown E. Renal Failure and Severe Hypokalemia Associated With Acute Myelomonocytic Leukemia American Journal Of Kidney Diseases 1993, 22: 462-467. PMID: 8372846, DOI: 10.1016/s0272-6386(12)70154-3.
• Successful Treatment of Cystinuria With CaptoprilPerazella M, Buller G. Successful Treatment of Cystinuria With Captopril American Journal Of Kidney Diseases 1993, 21: 504-507. PMID: 8488818, DOI: 10.1016/s0272-6386(12)80396-9.
• Posttransplant erythrocytosis: case report and review of newer treatment modalities.Perazella MA, Bia MJ. Posttransplant erythrocytosis: case report and review of newer treatment modalities. Journal Of The American Society Of Nephrology 1993, 3: 1653-9. PMID: 8318681, DOI: 10.1681/asn.v3101653.
• Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis.Perazella M, Eisen T, Brown E. Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 1993, 21: 319-21. PMID: 8447310, DOI: 10.1016/s0272-6386(12)80753-0.
• Can Ibuprofen Cause Acute Renal Failure in a Normal Individual? A Case of Acute OverdosePerazella M, Buller G. Can Ibuprofen Cause Acute Renal Failure in a Normal Individual? A Case of Acute Overdose American Journal Of Kidney Diseases 1991, 18: 600-602. PMID: 1951342, DOI: 10.1016/s0272-6386(12)80657-3.
• Hemorrhagic bursitis complicating treatment with recombinant tissue plasminogen activatorPerazella M, Buller G. Hemorrhagic bursitis complicating treatment with recombinant tissue plasminogen activator The American Journal Of Medicine 1991, 91: 440-442. PMID: 1951393, DOI: 10.1016/0002-9343(91)90168-w.
• Ace inhibitor-induced hypoglycemiaBuller G, Perazella M. Ace inhibitor-induced hypoglycemia The American Journal Of Medicine 1991, 91: 104-105. PMID: 1858823, DOI: 10.1016/0002-9343(91)90092-c.